Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TOP1MT | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | KIF21B | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
mRNA | CAV2 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
mRNA | DMRTB1 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
mRNA | THUMPD2 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
mRNA | TOMM6 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
mRNA | ANKRD22 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
mRNA | F12 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | GTF2A1L | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
mRNA | SMYD2 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |